
News from csimarket.com
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top csimarket.com News

Europe · GermanyBioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy candidates. Analysts say the M&A deal is a way to essentially settle out of court the ongoing mRNA patent dispute between the companies following some recent CureVac legal wins. The post BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute appeared first on MedCity News.See the Story
BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute
45% Center coverage: 27 sources

Hepatitis C · United StatesEditor's Note: This headline and story have been updated to clarify that the FDA approval was for an expanded indication to treat acute HCV. The U.S. Food and Drug Administration (FDA) approved a label expansion for AbbVie Inc's (NYSE:ABBV) Mavyret (glecaprevir/pibrentasvir) to include treatment of acute hepatitis C virus (HCV) infection in patients without cirrhosis or with compensated cirrhosis. Glecaprevir, one of the two DAAs in Mavyret, was…See the Story
FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED) - Enanta Pharma (NASDAQ:ENTA), AbbVie (NYSE:ABBV)
73% Center coverage: 15 sources
Supermajor TotalEnergies Boosts AI Use in Its Energy Strategy
Coverage: 2 sources
#Inception Growth Acquisition: A Strategic Extension for a Game-Changing Business Combination,
#A Strategic Voyage: Toro Corp. Strengthens Its Fleet in the Race for Energy Transportation Supremacy
Market Rally as Oracle Leaps: A Mixed Day for Investors Amid Global Concerns $ GME $ Know Before # Stock Market Opens # Fetch.ai
#s with its shareholders recently rejecting a civil liberties proposal while approving executive pay. This outcome sig...
Price Over Earnings Overview: Oshkosh - Oshkosh (NYSE:OSK)
100% Center coverage: 1 sources